Almirall opens Shanghai hub to power dermatology innovation and China partnerships
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
Cognita CXR leverages a proprietary vision-language model to analyze full chest X-ray studies and generate comprehensive preliminary findings
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
ShunzymeX leverages a proprietary protease to streamline purification
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
It is also approved for?AIDS-related Kaposi sarcoma?after failure of highly active antiretroviral therapy, as well as for HIV-negative adult patients with Kaposi sarcoma
Subscribe To Our Newsletter & Stay Updated